BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 4544019)

  • 1. Facilitation of metastasis by antithymocyte globulin.
    James SE; Salsbury AJ
    Cancer Res; 1974 Feb; 34(2):367-70. PubMed ID: 4544019
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancing T lymphocytes from tumor-bearing mice suppress host resistance to a syngeneic tumor.
    Treves AJ; Carnaud C; Trainin N; Feldman M; Cohen IR
    Eur J Immunol; 1974 Nov; 4(11):722-7. PubMed ID: 4547711
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract]   [Full Text] [Related]  

  • 4. Abrogation of the anti-metastatic activity of C. parvum by antilymphocyte serum.
    Sadler TE; Castro JE
    Br J Cancer; 1976 Sep; 34(3):291-5. PubMed ID: 1086096
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
    Thomas F; Berry R; Mendez-Picon G; Thomas J; Lower RR; Lee HM
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():56-61. PubMed ID: 386321
    [No Abstract]   [Full Text] [Related]  

  • 6. Suppressor cell activation by anti-thy 1.2 in NZB/WF1 mice.
    Klassen LW; Zarate A; Gelfand MC; Steinberg AD
    J Immunol; 1977 Dec; 119(6):2067-72. PubMed ID: 334981
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of hematopoiesis after treatment with antithymocyte serum and erythropoietin.
    Kinnamon KE; Blackwell LH; Ledney GD
    Exp Hematol; 1974; 2(4):204-11. PubMed ID: 4616844
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of antithymocyte serum on growth and metastasis of murine tumor].
    Yu JG
    Zhonghua Zhong Liu Za Zhi; 1984 Jan; 6(1):12-4. PubMed ID: 6611248
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal conditions for the growth of malignant human and animal cell populations in immunosuppressed mice.
    Stanbredge EJ; Boulger LR; Franks CR; Garrett JA; Reeson DE; Bishop D; Perkins FT
    Cancer Res; 1975 Aug; 35(8):2203-12. PubMed ID: 1080073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the effect on allograft response of allogeneic and xenogeneic antisera in mice.
    Hilgert I; Pokorná Z; Kristofová H; Vlachov K
    Folia Biol (Praha); 1974; 20(2):116-24. PubMed ID: 4611803
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppression by antilymphocyte serum and its effect on tumors indduced by 3-methylcholanthrene in mice.
    Wagner JL; Haughton G
    J Natl Cancer Inst; 1971 Jan; 46(1):1-10. PubMed ID: 5546191
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on heterologous antilymphocyte and antithymocyte sera. V. Loss or retention of immunosuppressive activity after absorption with sheep erythrocytes.
    Barth RF; Singla O
    J Immunol; 1972 Nov; 109(5):1003-8. PubMed ID: 4562422
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer in immunosuppressed experimental animals and human patients.
    Allison AC
    Johns Hopkins Med J Suppl; 1974; 3():341-51. PubMed ID: 4370940
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on heterologous antilymphocyte serum in mice. 8. Effect of immunizing cell type and dose on immunosuppressive potency and content of irrelevant antibody.
    Gozzo JJ; Wood ML; Monaco AP
    Transplantation; 1972 Sep; 14(3):352-7. PubMed ID: 4564931
    [No Abstract]   [Full Text] [Related]  

  • 15. Antithymocyte globulin (ATG) and trenimon (TR): effects on T cells and graft rejection.
    Beatty JD; Friesen E; Linford JH; Israels LG
    Surg Forum; 1977; 28():327-9. PubMed ID: 364726
    [No Abstract]   [Full Text] [Related]  

  • 16. Rabbit anti-mouse thymocyte antibody as an adjuvant in the preparation of further anti-thymocyte sera.
    Lai T; Symes MO
    Immunology; 1977 Sep; 33(3):387-90. PubMed ID: 302825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune stimulation-inhibition of experimental cancer metastasis.
    Fidler IJ
    Cancer Res; 1974 Mar; 34(3):491-8. PubMed ID: 4812256
    [No Abstract]   [Full Text] [Related]  

  • 18. Depression of alloantigens in malignancy. Evidence for tumour susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in the microcytotoxicity assay.
    Martin WJ; Esber E; Cotton WG; Rice JM
    Br J Cancer Suppl; 1973 Aug; 1():48-61. PubMed ID: 4804290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression versus immunity in syngeneic and allogeneic tumours.
    Vlachov K; Nouza K
    Neoplasma; 1973; 20(1):3-12. PubMed ID: 4573871
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival of tumor allografts in rats treated with antithymocyte serum.
    Abandowitz HM; Basrur PK
    Z Naturforsch C; 1973; 28(9):631-2. PubMed ID: 4272308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.